Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Houston, Texas 77030


The purpose of this study is to: a) evaluate the effectiveness of ondansetron (Zofran) in the treatment of alcohol dependent patients; b) investigate whether early versus late onset alcoholism predicts treatment outcome; and c) determine whether the early and late onset groups respond differently to treatment. Individuals will be "typed" into early onset and late onset alcoholism groups. Individuals will be randomly assigned to a 12-week outpatient treatment program.


Inclusion Criteria: - Meet criteria for alcohol dependence. - Subjects with early onset alcoholism must also have a diagnosis of antisocial personality disorder. - Understand the requirements of the study and be able to complete the questionnaires and rating scales. Exclusion Criteria: - Current diagnosis of substance dependence or self-report of having used narcotics (opiates, cocaine, amphetamine-like substances, and hallucinogens) in the 30 day period prior to study. - Positive urine drug screen test for narcotics, barbiturates, or benzodiazepines. - Receiving current psychotropic medications. - Current history of other psychiatric disorders excluding nicotine dependence. - Hepatocellular disease. - Pregnant females.



Primary Contact:


Backup Contact:


Location Contact:

Houston, Texas 77030
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: October 18, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.